Search research articles
Contact Us
Filters
Showing results (231-240 of 317) with videos related to
Page
of 32
Sort By:
British Journal of Cancer
|
April 26, 2012
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
S Kaye, S Aamdal, R Jones, et al.
NPJ Digital Medicine
|
July 16, 2019
Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study
Daniel S W Ting, Carol Y Cheung, Quang Nguyen, et al.
Investigative Ophthalmology & Visual Science
|
July 2, 2016
Characterization of Fatty Acid Binding Protein 7 (FABP7) in the Murine Retina
Xinyi Su, Queenie S W Tan, Bhav H Parikh, et al.
Diabetes
|
January 30, 2016
Plasma Metabonomic Profiling of Diabetic Retinopathy
Liyan Chen, Ching-Yu Cheng, Hyungwon Choi, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Human Genomics
|
July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Ning-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Scientific Reports
|
March 28, 2020
25-years Trends and Risk factors related to Surgical Outcomes of Giant Retinal Tear-Rhegmatogenous Retinal Detachments
Daniel S W Ting, Valencia H X Foo, Tien-En Tan, et al.
Blood
|
July 13, 2017
Strict tropism for CD71<sup>+</sup>/CD234<sup>+</sup> human reticulocytes limits the zoonotic potential of <i>Plasmodium cynomolgi</i>
Varakorn Kosaisavee, Rossarin Suwanarusk, Adeline C Y Chua, et al.
JTO Clinical and Research Reports
|
June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLC
Alexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
A J Schoenfeld, S J Antonia, M M Awad, et al.
Page
of 32
Search research articles
Search
Showing results (231-240 of 317) with videos related to
Sort By:
Page
of 32
British Journal of Cancer
|
April 26, 2012
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
S Kaye, S Aamdal, R Jones, et al.
NPJ Digital Medicine
|
July 16, 2019
Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study
Daniel S W Ting, Carol Y Cheung, Quang Nguyen, et al.
Investigative Ophthalmology & Visual Science
|
July 2, 2016
Characterization of Fatty Acid Binding Protein 7 (FABP7) in the Murine Retina
Xinyi Su, Queenie S W Tan, Bhav H Parikh, et al.
Diabetes
|
January 30, 2016
Plasma Metabonomic Profiling of Diabetic Retinopathy
Liyan Chen, Ching-Yu Cheng, Hyungwon Choi, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Human Genomics
|
July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Ning-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Scientific Reports
|
March 28, 2020
25-years Trends and Risk factors related to Surgical Outcomes of Giant Retinal Tear-Rhegmatogenous Retinal Detachments
Daniel S W Ting, Valencia H X Foo, Tien-En Tan, et al.
Blood
|
July 13, 2017
Strict tropism for CD71<sup>+</sup>/CD234<sup>+</sup> human reticulocytes limits the zoonotic potential of <i>Plasmodium cynomolgi</i>
Varakorn Kosaisavee, Rossarin Suwanarusk, Adeline C Y Chua, et al.
JTO Clinical and Research Reports
|
June 6, 2022
Long-Term Efficacy and Safety of Entrectinib in <i>ROS1</i> Fusion-Positive NSCLC
Alexander Drilon, Chao-Hua Chiu, Yun Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
A J Schoenfeld, S J Antonia, M M Awad, et al.
Page
of 32